Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Vudalimab (Anti-CTLA4 & PD-1)

Product Specifications

CAS Number

2329669-72-7

Synonyms

XmAb 20717

SKU

C00929-1mg

Target

PD-1/PD-L1

Applications

Apoptosis

Additionnal Information

Vudalimab is a bispecific antibody targeting PD-1 and CTLA-4 to inhibit immune checkpoint regulation and enhance immune responses. It is being developed for the treatment of advanced malignancies by promoting T-cell activation against tumors and metastatic castration-resistant prostate cancer (mCRPC) . M.W 125.43 kDa

Storage Conditions

-80°C (avoid freeze-thaw cycles)

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

ATG10 Recombinant Rabbit Monoclonal Antibody [JE59-86]
HA721444 100 µL

ATG10 Recombinant Rabbit Monoclonal Antibody [JE59-86]

Sign In for Pricing
View Details
Frozen Tissue Sections, Prostate
CS508775 5x 5 µm

Frozen Tissue Sections, Prostate

Sign In for Pricing
View Details
3,4-diisopropoxybenzoic acid
TRC-D283485-250MG 250 mg

3,4-diisopropoxybenzoic acid

Sign In for Pricing
View Details
CD45RB (B-Cell Marker) (N/A), CF488A conjugate, 0.1mg/mL
BNC881794-100 1x 100 µL

CD45RB (B-Cell Marker) (N/A), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Omega-Muricholic Acid
TRC-M732760-2.5MG 2.5 mg

Omega-Muricholic Acid

Sign In for Pricing
View Details
WFDC5 (NM_145652) Human Over-expression Lysate
LC403436 20 µg

WFDC5 (NM_145652) Human Over-expression Lysate

Sign In for Pricing
View Details